A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk

Hao Zhang, Jie‐Mei Gu, Aijun Chao, Qun Cheng, Donghui Teng, Jinming Yu, Bing‐Wu Wang, Yanan Huo, Li Mao, Qiu Zhang, Hong Yang, Shigui Yan, Keqin Zhang, Xueling Zhao, Hua Lin, Yu Pei, Zhong Yuan, Ru-Chun Dai, Liang He, Li Chen, Yong-Feng Su, Zhong‐Liang Deng, You Li, Bo Ban, Mei Zhu, You-liang Cao, Yikun Zhu, Zhijun Li, Zhi Zhang, Chengqing Yi, Yibing Lu, Guang Wang, Cuicui Han, Zhenjiang Wang, Xian-xing Li, Zhenlin Zhang, Zhenlin Zhang, Zhenlin Zhang